v3.26.1
Summary of Significant Accounting Policies (Tables)
12 Months Ended
Dec. 31, 2025
Accounting Policies [Abstract]  
Schedule of Accounts Receivable

The following is a summary of the Company’s accounts receivable at December 31, 2025 and 2024:

 

   December 31,
2025
   December 31,
2024
 
Accounts receivable  $2,108,395   $1,696,436 
Less: allowance for doubtful accounts   69,181    81,772 
Accounts receivable – net  $2,039,214   $1,614,664 
Schedule of Bad Debt

For the years ended December 31, 2025 and 2024, bad debt was as follows:

 

   December 31,
2025
   December 31,
2024
 
Bad debt expense  $5,654   $41,836 
Schedule of Concentration of Risk

The following table presents customers and vendors that individually accounted for more than 10% of total sales, accounts receivable, or vendor purchases in the comparative periods presented:

 

Sales

 

   Year Ended December 31, 
Customer  2025   2024 
A   6.43%   20.19%
B   3.10%   9.72%
C   

52.16

%   -%
Total   29.91%   29.91%

 

Accounts Receivable

 

   Year Ended December 31,   Year Ended December 31, 
Customer  2025   2024 
A   22.42%   37.56%
B   4.22%   8.54%
C   

20.17

%   -%
D   10.73%   5.59%
Total   46.10%   46.10%

 

Vendor Purchases

 

   Year Ended December 31, 
Vendor  2025   2024 
A   19.37%   40.48%
B   11.02%   34.43%
C   4.74%   13.69%
D   59.89%   1%
Total   98.60%   98.60%
Schedule of Disaggregation of Revenue

The following represents the Company’s disaggregation of revenues for the years ended December 31, 2025 and 2024:

 

   Year Ended December 31, 
   2025   2024 
   Revenue   % of Revenues   Revenue   % of Revenues 
                 
Fuel sales  $79,001,833    96.54%  $26,694,186    96.13%
Other   2,833,446    3.46%   1,076,093    3.87%
Total Sales  $81,835,279    100.00%  $27,770,279    100.00%
Schedule of Dilutive Equity Securities Outstanding

The following potentially dilutive equity securities outstanding as of December 31, 2025 and 2024 were as follows: 

 

   December 31, 2025   December 31, 2024 
Series A, preferred stock   61,810    1,644,022 
Series B, preferred stock   724,638    724,638 
Series A, preferred stock - dividends   31,706    61,204 
Series B, preferred stock - dividends   21,739    32,372 
Warrants (vested)   2,735,895    46,344 
Total common stock equivalents   3,575,788    2,508,580